Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A recent study of the direct-acting antiviral regimen included people who contracted hep C within the previous 12 months.
All people ages 18 to 79 should be screened for hepatitis C virus at least once, regardless of risk factors.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
These two men both recently discovered that they had hepatitis C, each with a different story about their encounters with insurance.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
The group focuses on treatment, research, policy and education around HIV and hepatitis C.
Diagnosed with hepatitis C and HIV, Gloria Searson became a powerful advocate for many.
People who have a low CD4 count, have cirrhosis and take certain hep C drug regimens are less likely to be cured.
Cured of hepatitis C the hard way, Glenna McCarthy’s mission is to help others take advantage of the new easier-to-take treatments.
Human rights activist Philip Baldwin writes about his experiences living with hepatitis C and HIV, and his treatment for hep C.
Hepatitis C takes this storyteller from fear to action, helping others along the way.
The update includes a new combination therapy that can treat all six genotypes of HCV, a new HIV medication and PrEP.
This advocate’s call to action began with an injury, then a viral hepatitis diagnosis, then HIV.
Even those who did not qualify for a treatment shorter than 12 weeks did well on the regimen in a real-world study.
Gilead Sciences’ HCV combo tablet regimen of Sovaldi and velpatasvir can be combined safely with most “boosted” antiretroviral treatment...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.